Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force).

Carcinoid Heart Disease / diagnostic imaging Echocardiography Humans Neuroendocrine Tumors / diagnostic imaging Prospective Studies
carcinoid heart disease echocardiography neuroendocrine neoplasia synoptic reporting

Journal

Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461

Informations de publication

Date de publication:
03 2022
Historique:
received: 21 09 2021
accepted: 30 10 2021
pubmed: 27 11 2021
medline: 20 4 2022
entrez: 26 11 2021
Statut: ppublish

Résumé

This European Neuroendocrine Tumor Society (ENETS) Expert Consensus document aims to provide practical guidance and standardization for echocardiography in the screening and follow-up of carcinoid heart disease (CHD) in patients with a neuroendocrine tumour (NET) and carcinoid syndrome. NET experts within the ENETS Carcinoid Heart Disease Task Force reviewed both general reporting guidelines and specialized scoring systems for transthoracic echocardiography (TTE) in CHD. Based on this review, a dedicated template report was designed by the multidisciplinary working group of cardiologists, oncologists, endocrinologists, gastroenterologists, surgeons and radiologists. We propose a Synoptic Reporting of Echocardiography in Carcinoid Heart Disease which represents an agreed peer reviewed proforma to capture information at the time of referral and enable a detailed outcome of CHD assessment. This includes a systematic and detailed list of structures to evaluate data to capture at the time of reporting of TTE. Adherence to these reporting guidelines aims to promote homogeneous and detailed evaluation of CHD to secure accurate assessment and allow comparison of studies performed intra- and inter-individually. These guidelines could also facilitate CHD assessment as part of prospective clinical trials to enable standardization of the findings seen in response to therapy.

Sections du résumé

BACKGROUND
This European Neuroendocrine Tumor Society (ENETS) Expert Consensus document aims to provide practical guidance and standardization for echocardiography in the screening and follow-up of carcinoid heart disease (CHD) in patients with a neuroendocrine tumour (NET) and carcinoid syndrome.
METHODS
NET experts within the ENETS Carcinoid Heart Disease Task Force reviewed both general reporting guidelines and specialized scoring systems for transthoracic echocardiography (TTE) in CHD. Based on this review, a dedicated template report was designed by the multidisciplinary working group of cardiologists, oncologists, endocrinologists, gastroenterologists, surgeons and radiologists.
RESULTS
We propose a Synoptic Reporting of Echocardiography in Carcinoid Heart Disease which represents an agreed peer reviewed proforma to capture information at the time of referral and enable a detailed outcome of CHD assessment. This includes a systematic and detailed list of structures to evaluate data to capture at the time of reporting of TTE.
CONCLUSIONS
Adherence to these reporting guidelines aims to promote homogeneous and detailed evaluation of CHD to secure accurate assessment and allow comparison of studies performed intra- and inter-individually. These guidelines could also facilitate CHD assessment as part of prospective clinical trials to enable standardization of the findings seen in response to therapy.

Identifiants

DOI: 10.1111/jne.13060 PMID: 34825753 PMC: PMC9286034
pubmed: 34825753
doi: 10.1111/jne.13060
pmc: PMC9286034
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13060

Investigateurs

Ashley K Clift (A)
Wanda Geilvoet (W)
Enrique Grande (E)
Ulrich-Frank Pape (UF)
Vikas Prasad (V)
Marie-Louise van Velthuysen (ML)
Thomas Walter (T)
Staffan Welin (S)

Informations de copyright

© 2021 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.

Références

J Neuroendocrinol. 2022 Mar;34(3):e13105
pubmed: 35233848
Open Heart. 2019 Jun 4;6(1):e001060
pubmed: 31245014
Am Heart J. 1996 Jul;132(1 Pt 1):145-51
pubmed: 8701857
J Neuroendocrinol. 2022 Mar;34(3):e13054
pubmed: 34739148
Schweiz Med Wochenschr. 1953 Jan 3;83(1):4-7
pubmed: 13056533
J Cardiovasc Comput Tomogr. 2021 Mar-Apr;15(2):167-174
pubmed: 33004299
Eur Heart J Cardiovasc Imaging. 2017 Dec 01;18(12):1301-1310
pubmed: 29045589
Neuroendocrinology. 2018;106(2):139-147
pubmed: 28384635
Clin Oncol (R Coll Radiol). 2015 Dec;27(12):741-6
pubmed: 26170123
Circ Cardiovasc Imaging. 2016 Dec;9(12):
pubmed: 27974407
J Neuroendocrinol. 2022 Mar;34(3):e13040
pubmed: 34668262
Echo Res Pract. 2020 Dec;7(4):G95-G122
pubmed: 33339003
Curr Probl Cardiol. 2008 Feb;33(2):47-84
pubmed: 18222317
Lancet Oncol. 2017 Apr;18(4):525-534
pubmed: 28238592
Neuroendocrinology. 2009;90(2):190-3
pubmed: 19713710
Circulation. 1993 Apr;87(4):1188-96
pubmed: 7681733
Am Heart J. 1954 Jun;47(5):795-817
pubmed: 13158264
Neuroendocrinology. 2015;101(4):263-73
pubmed: 25871411
Br J Surg. 2001 Jun;88(6):865-72
pubmed: 11412260
J Cardiol. 2016 Jun;67(6):485-92
pubmed: 26917197
Am J Cardiol. 2008 Oct 1;102(7):938-42
pubmed: 18805126
J Am Coll Cardiol. 1998 Oct;32(4):1017-22
pubmed: 9768727
N Engl J Med. 2003 Mar 13;348(11):1005-15
pubmed: 12637610
J Neuroendocrinol. 2022 Mar;34(3):e13060
pubmed: 34825753
J Neuroendocrinol. 2022 Mar;34(3):e13044
pubmed: 34693574
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Am J Cardiol. 2010 Jun 1;105(11):1588-91
pubmed: 20494667
Am J Cardiol. 2011 Apr 15;107(8):1221-6
pubmed: 21296329
Cardiol Young. 2006 Sep;16 Suppl 3:4-11
pubmed: 17378035
Circ Cardiovasc Imaging. 2017 Nov;10(11):
pubmed: 29042413
Circ Cardiovasc Imaging. 2010 Jan;3(1):103-11
pubmed: 19920029
J Neuroendocrinol. 2022 Mar;34(3):e13100
pubmed: 35165954
ISRN Oncol. 2013;2013:420795
pubmed: 23533809
Curr Opin Cardiol. 2017 Sep;32(5):529-540
pubmed: 28678047
J Am Soc Echocardiogr. 2014 Aug;27(8):797-810
pubmed: 25085408
J Surg Oncol. 2005 Mar 1;89(3):151-60
pubmed: 15719376
J Anat. 2004 Sep;205(3):159-77
pubmed: 15379923
J Am Soc Echocardiogr. 2019 Jan;32(1):1-64
pubmed: 30282592
J Am Coll Cardiol. 2017 Mar 14;69(10):1288-1304
pubmed: 28279296
Neuroendocrinology. 2014;99(2):85-93
pubmed: 24603343
Int J Cardiovasc Imaging. 2007 Dec;23(6):717-24
pubmed: 17318363

Auteurs

Johannes Hofland (J)

Department of Internal Medicine, Section of Endocrinology, ENETS Center of Excellence, Erasmus MC and Erasmus Cancer Institute, Rotterdam, The Netherlands.
ORCID: 0000-0003-0679-6209

Angela Lamarca (A)

Department of Medical Oncology, The Christie NHS Foundation, Manchester, UK.
Division of Cancer Sciences, University of Manchester, Manchester, UK.

Richard Steeds (R)

Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust and Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.

Christos Toumpanakis (C)

Centre for Gastroenterology, Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK.

Rajaventhan Srirajaskanthan (R)

Department of Gastroenterology, Neuroendocrine Tumour Unit, Kings College hospital, London, UK.

Rachel Riechelmann (R)

Department of Clinical Oncology, AC Camargo Cancer Center, São Paulo, Brazil.

Francesco Panzuto (F)

Digestive Disease Unit, Sant' Andrea University Hospital, ENETS Center of Excellence, Rome, Italy.
ORCID: 0000-0003-2789-4289

Andrea Frilling (A)

Department of Surgery and Cancer, Imperial College London, London, UK.

Timm Denecke (T)

Department of Diagnostic and Interventional Radiology, Leipzig University Medical Center, Leipzig, Germany.

Emanuel Christ (E)

Division of Endocrinology, Diabetology and Metabolism, ENETS Centre of Excellence, University Hospital Basel, Basel, Switzerland.

Simona Grozinsky-Glasberg (S)

Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Joseph Davar (J)

Royal Free Hospital & University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies cardiovasculaires › Cardiopathies › Cardiopathie carcinoïde › Synoptic reporting of echocardiography in...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic cardiovasculaire › Tests de la fonction cardiaque › Échocardiographie › Synoptic reporting of echocardiography in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Synoptic reporting of echocardiography in...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Synoptic reporting of echocardiography in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Synoptic reporting of echocardiography in...